Literature DB >> 3115596

Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.

D T Harris1, W J Kozumbo, P A Cerutti, J C Cerottini.   

Abstract

The effects of cyclosporin A (CyA) on the activation processes of cloned murine cytotoxic T lymphocytes (CTL) have been examined. With the use of Day 7 resting cloned CTL it was possible to separate the functions of lymphokine production (macrophage-activating factor, MAF) and interleukin 2 (IL-2)-induced proliferation of these cells. The effect of CyA on each of these activities was analyzed independently. CyA was found to inhibit both receptor-mediated MAF production in response to stimulation with antigen and lectin and MAF production in response to non-receptor-mediated stimulation (by anti-Thy-1 antibodies, ionophore, and phorbol ester). Further, CyA was observed to inhibit the re-entry of these resting CTL into the cell cycle upon stimulation with IL-2. The effect of CyA on MAF production did not appear to be due to inhibition of the signal-transducing mechanism involved in this process (i.e., inositol lipid hydrolysis, calcium mobilization, and protein phosphorylation). The action of CyA on the IL-2-induced proliferation was not due to inhibition of IL-2 receptor expression or the binding of IL-2 to its receptor. Thus, CyA appeared to mediate its suppressive effects on MAF production and IL-2-induced proliferation through an action on some later step(s) in the signal pathways of these activities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115596     DOI: 10.1016/0008-8749(87)90296-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

Review 1.  Cyclosporin for Crohn's disease?

Authors:  M Guslandi; A Tittobello
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

2.  Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells.

Authors:  R D Huby; G Janossy; I A Lampert
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

3.  In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains.

Authors:  S Caillat-Zucman; L Chatenoud; J F Bach
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

4.  Cyclosporin A treatment in inflammatory bowel disease.

Authors:  E F Stange; W E Fleig; E Rehklau; H Ditschuneit
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

Review 5.  Cyclosporin A for primary biliary cirrhosis.

Authors:  Y Gong; E Christensen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.